Ebola Cases in DR Congo Top 11,000 as Bundibugyo Outbreak Becomes Second-Largest on Record

At least 5,387 people have died, many outside treatment centres, across eight of the DRC's 26 provinces.
Many deaths have occurred outside treatment centres
Eight of the DRC's 26 provinces are affected, and many victims never reached care.

On a Tuesday in November, the Democratic Republic of the Congo reported 11,042 confirmed Ebola cases and at least 5,387 deaths, making this the second-largest outbreak the world has recorded, surpassed only by West Africa's catastrophe a decade ago. The culprit is the Bundibugyo strain, which has no dedicated vaccine or treatment and kills roughly half of those it infects. Delayed detection, armed conflict, and health systems already stretched thin have allowed it to travel across eight of the country's 26 provinces, and many of the dead never reached a clinic. Hope now rests on vaccine trials, approved this month, whose results are not expected until early 2027.

On Tuesday, the Democratic Republic of the Congo released figures that confirmed what health workers had been warning for weeks: 11,042 confirmed cases and at least 5,387 deaths. This is the largest and deadliest Ebola outbreak the country has ever faced, and containment is proving brutally difficult.

The culprit is the Bundibugyo strain, a rare form of Ebola that kills about half of those it infects. No vaccine or treatment has been developed specifically for it, so responders are working with few tools against a fast-moving threat.

The outbreak now ranks as the second-largest on record, behind only the 2014 to 2016 epidemic in West Africa. Eight of the DRC's 26 provinces are affected, and many of the dead died outside treatment centres, sick people who never reached care in time. Cases have also appeared across East, Central and West Africa.

Officials point to delayed detection, conflict and overstretched health services as the forces that let the virus outpace earlier outbreaks. Violence compounds the crisis: armed men recently killed at least 33 people in a village in the affected east.

The one note of progress is medical. The World Health Organization approved clinical trials of two new Ebola vaccines earlier this month, with results expected in early 2027. Until then, communities will face the outbreak without a vaccine designed for this strain.

On Tuesday, the Democratic Republic of the Congo's government released its latest Ebola figures: 11,042 confirmed cases and at least 5,387 deaths. The numbers confirm what health authorities have been saying for weeks. This is the largest and deadliest Ebola outbreak the country has ever faced, and they are struggling to contain it.

The cause is the Bundibugyo strain, a rare species of the Ebola virus. It kills about half of the people it infects. Unlike with other strains, no vaccine or treatment has been developed specifically for it, which has made containment especially hard.

The outbreak now ranks as the second-largest and second-deadliest Ebola outbreak on record. Only the 2014-2016 epidemic in West Africa was bigger. That epidemic infected more than 28,600 people and killed more than 11,000.

The geography is wide. Eight of the DRC's 26 provinces have been affected. Many of the deaths have occurred outside treatment centres, which points to people who were sick but never reached care, or who did not reach it in time. Cases have also been reported in East, Central and West Africa, giving this outbreak the widest geographic spread of any Ebola outbreak on the continent so far.

The reporting identifies three factors behind the virus's faster spread compared with earlier outbreaks: delayed detection, conflict, and strained health services. Violence is part of the picture. Among related reports, armed men killed at least 33 people in a village in Ebola-hit eastern DRC.

There is some movement on the medical side. Earlier this month, the World Health Organization approved clinical trials of two new Ebola vaccines. The agency said it expects results in early 2027. That leaves months in which the outbreak will continue without a vaccine designed for this strain.

What to watch next: whether the case count keeps climbing in the eight affected provinces, whether the spread across three African regions widens, and whether the vaccine trials begin on schedule and report in early 2027 as planned.

The WHO approved clinical trials of two new Ebola vaccines and expects results in early 2027.
— World Health Organization
Quieres la nota completa? Lee el original en Al Jazeera ↗
Contáctanos FAQ